CLASS II ONGOING Device recall · Reported 27 Apr 2022 · FDA Enforcement Report

therascreen KRAS RGQ PCR Kit recalled by Qiagen Sciences

Qiagen Sciences is recalling therascreen KRAS RGQ PCR Kit, distributed in 14 states. The recall was initiated on 25 Feb 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lot numbers
Quantity recalled8 Kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0952-2022
FDA event ID
89914
Recalling firm
Qiagen Sciences, Germantown, MD
Classification
Class II
Status
Ongoing
Recall initiated
25 Feb 2022
FDA classified
18 Apr 2022
Reported
27 Apr 2022
Type
Voluntary: Firm initiated
Reason category
Other Reasons

Timeline

25 Feb 2022Recall initiated by company
18 Apr 2022Classified by FDA+52 days
27 Apr 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutation target of the kit.

Product as listed by the FDA

therascreen KRAS RGQ PCR Kit (24) REF 874052 (Japan IVD, not released in the USA)

Where it was distributed

AZ CA CT FL GA IL IN MA MN NC NY OK OR PA TN TX WV

ArizonaCaliforniaConnecticutFloridaGeorgiaIllinoisMassachusettsMinnesotaNorth CarolinaNew YorkPennsylvaniaTennesseeTexasWest Virginia

Questions about this recall

Why was it recalled?

False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutation target of the kit.

Which lots are affected?

All lot numbers

Where was it sold?

AZ CA CT FL GA IL IN MA MN NC NY OK OR PA TN TX WV

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 89914

This product is part of a recall event; the main page for the event is therascreen KRAS RGQ PCR Kit recalled by Qiagen Sciences.

ReportedClassRecallCompanyReasonWhere
CLASS IItherascreen KRAS RGQ PCR Kit recalled by Qiagen SciencesQiagen SciencesOther14 states

More recalls from Qiagen Sciences

All 23

Other Test Kits & Diagnostics recalls

All 2,675
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IINextseq 550Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IINovaSeq 6000Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IILiaison Plex Gram-Negative Blood Culture Assay recalled by LuminexLuminexPotency & AssayNationwide
DeviceCLASS IIMiSeq Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IITechno-Path Multichem AE Unassayed Level recalledTechno-path ManufacturingPotency & AssayNationwide